AGILeBiotics B.V. logo

AGILeBiotics B.V.

We are passionately translating innovation into novel antibiotics for the treatment of multidrug-resistant infections!

1 employees · est. 2017 · Groningen, The Netherlands

VS
ANTABIO logo

ANTABIO

Developing Tomorrow's Antibacterials

25 employees · est. 2009 · France

ANTABIO is the older company (2017 vs 2009); ANTABIO is the larger of the two.

Side-by-Side Comparison

AGILeBiotics B.V. ANTABIO
Founded
2017 2009 older
Headquarters
Groningen, The Netherlands France
Employees
1 25 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Life Sciences, Medical Devices
Funding Stage
Seed Series B
Total Funding
Not tracked yet $52.23M
Funding Rounds
1 16
Services
Category search engine, Information aggregation, User-focused content navigation Not tracked yet
Target Customers
Consumers seeking categorized content, Individuals interested in diverse sectors like automotive and health, Online shoppers, Travel enthusiasts Not tracked yet
Taxonomy
Antibiotic Development, Multidrug-resistant Infections, Pharmaceutical Research, Natural Product-based Antibiotics, Lead Optimization, Drug Discovery, Antibacterial Research, Selective Modification, Life-threatening Infections, Hospital-acquired Infections, Early-stage Pharmaceutical Biopharmaceutical, Antibacterial Treatments, Drug-resistant Infections, Metalloenzymes Inhibitors, Bacterial Metallo ß-lactamases, Carbapenem Combination, Drug Discovery, Drug Development, Antibiotic Adjuvant, Nosocomial Infections, Clinical-stage, Wellcome Trust Seeding Drug Discovery Award, Labege, France
Website
agilebiotics.com antabio.com
AGILeBiotics B.V. logo

About AGILeBiotics B.V.

AGILeBiotics B.V., a spin-off from University of Groningen, is at the forefront of biotechnology and healthcare, focusing on the critical field of antibiotic research. Founded in 2017, the company is strategically located in the Innolab Chemie Groningen in The Netherlands. The company is passionate...

ANTABIO logo

About ANTABIO

Antabio is a privately-held clinical-stage biopharmaceutical company founded in 2009, with a focus on developing novel and highly differentiated antibacterial treatments for drug-resistant infections. The company operates in the biotechnology, life sciences, and medical devices industries and is bas...

We will tell you when either one moves

BounceWatch watches AGILeBiotics B.V. and ANTABIO for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AGILeBiotics B.V. and ANTABIO — by email.

Frequently Asked Questions

AGILeBiotics B.V. — We are passionately translating innovation into novel antibiotics for the treatment of multidrug-resistant infections! . ANTABIO — Developing Tomorrow's Antibacterials. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AGILeBiotics B.V. has raised undisclosed funding while ANTABIO has raised $52.23M.
AGILeBiotics B.V. and ANTABIO operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AGILeBiotics B.V. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AGILeBiotics B.V. on 2 Apr 2026, and ANTABIO on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy